COMMON PET IMAGING AGENTS IN BRAIN TUMORS

Abstract

With the rapid development of imaging techniques, the use of PET imaging has gradually become more widespread for the clinical diagnosis and treatment of brain tumors, demonstrating unique advantages in displaying the overall expression of tumor markers. PET imaging is now a new method for analyzing the molecular pathological characteristics of tumors and screening for targeted drugs. This technique allows the direct visualization of tumor biological processes at the molecular and cellular levels and enables the direct measurement of sugar, protein, lipid, and nucleotide metabolism; it is extensively applied in the diagnosis, classification, and efficacy evaluation of brain tumors.